Ads
related to: lcis found after breast reduction cancer survival rate- Clinical Trial Results
Learn About Clinical Trial Results
In Patients Like Yours.
- Request A Rep
Request a Representative & Discover
More About Treatment Option.
- Ordering Information
Find Out More About Ordering
A Treatment For Your Patients.
- Prescription Info
Find Dosing Guides & Safety
Information Here.
- Nurses Station
Explore Resources Made For Nurses
To Learn About A mTNBC Treatment.
- Oncology Co-Pay Program
Downloadable Resources Available
For Your Patients And Practice
- Clinical Trial Results
Search results
Results From The WOW.Com Content Network
The overall 5-year survival rate of lobular carcinoma in situ has been estimated to be 97%. [16] LCIS (lobular neoplasia is considered pre-cancerous) is an indicator (marker) identifying women with an increased risk of developing invasive breast cancer. This risk extends more than 20 years.
Invasive lobular carcinoma (ILC) is breast cancer arising from the lobules of the mammary glands. [1] It accounts for 5–10% of invasive breast cancer. [2] [3] Rare cases of this carcinoma have been diagnosed in men (see male breast cancer). [4]
Compared to other populations, they tend to have reduced chance of cure and a shorter survival after diagnosis if unable to be cured. [27] [28] [12] In 2003, one study found the five-year survival rate of invasive carcinoma NST was approximately 85%. [29]
The American Cancer Society reports 5-year relative survival rates of over 70% for women with stage 0-III breast cancer with a 5-year relative survival rate close to 100% for women with stage 0 or stage I breast cancer. The 5-year relative survival rate drops to 22% for women with stage IV breast cancer. [3]
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: lcis found after breast reduction cancer survival rate